Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 368-376

  Nicamhlaoibh, Róisín ^a   Heenan, Mary ^a   Cleary, Irene ^a   Touhey, Samantha ^a   O'Loughlin, Colette ^a   Daly, Carmel ^a   Nuñez, Gabriel ^b   Scanlon, Kevin J ^c   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENATE SODIUM; BETA ACTIN; CARBOPLATIN; CYCLOSPORIN A; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; THYMIDYLATE SYNTHASE; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; MULTIDRUG RESISTANCE; ONCOGENE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HUMANS; IN SITU NICK-END LABELING; LUNG NEOPLASMS; P-GLYCOPROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; VARIATION (GENETICS);

EID: 0033046903     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<368::AID-IJC10>3.0.CO;2-E     Document Type: Article

References (36)

1. ANTMAN, K. and 17 OTHERS, High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience. Cancer Treat. Rep., 71, 119-125 (1987).
2. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUÑEZ, G. and THOMPSON, C.B., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608 (1993).
3. CHENG, E.H.-Y., KIRSCH, D.G., CLEM, R.J., RAVI, R., KASTAN, M.B., BEDI, A., UENO, K. and HARDWICK, J.M., Conversion of Bcl-2 to a Bax-like death effector by caspases. Science, 278, 1966-1968 (1997).
4. CHEVILLARD, S., VIELH, P., BASTIAN, G. and COPPEY, J., A single 24h contact time with adriamycin provokes the emergence of resistant cells expressing the gp 170 protein. Anticancer Res., 12, 495-500 (1992).
5. L through caspase interaction. Proc. nat. Acad. Sci. (Wash.), 95, 554-559 (1998).
6. CLYNES, M. (ED)., Multiple drug resistance in cancer 2: cellular, molecular and clinical approaches, Kluwer, Dordrecht (1998).
7. CLYNES, M., DALY, C., NICAMHLAOIBH, R., CRONIN, D., ELLIOTT, C., O'CONNOR, R., O'DOHERTY, T., CONNOLLY, L., HOWLETT, A. and SCANLON, K., Recent developments in drug resistance and apoptosis research. Crit. Rev. Oncol./Haematol., 28, 181-205 (1998).
8. DAVEY, R. and DAVEY, M., The extended MDR phenotype. Cytotechnology, 27, 237-247 (1998).
9. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res., 55, 2576-2582 (1995).
10. DUFFY, C.P., ELLIOTT, C.J., O'CONNOR, R.A., HEENAN, M.M., COYLE, S., CLEARY, I.M., KAVANAGH, K., VERHAEGEN, S., O'LOUGHLIN, C.M., NICAMHLAOIBH, R. and CLYNES, M., Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Europ. J. Cancer, 34, 1250-1259 (1998).
11. L protein by caspase-3-like proteases. Oncogene, 17, 1295-1304 (1998).
12. FUJITA, N. and TSURUO, T., Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem. biophys. Res. Comm., 246, 484-488 (1998).
13. GORCZYCA, W., GONG, J., ARDELT, B., TRAGANOS, F. and DARZYNKIEWICZ, Z., The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumour agents. Cancer Res., 53, 3186-3192 (1993).
14. GRANDGIRARD, D., STUDER, E., MONNEY, L., FELLAY, I., BORNER, C. and MICHEL, M.R., Alphaviruses induce apoptosis in bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of bcl-2. EMBO J., 17, 1268-1278 (1998).
15. HARIGAI, M., MIYASHITA, T., HANADA, M. and REED, J.C., A cis-acting element in the BCL-2 gene controls expression through translational mechanisms. Oncogene, 12, 1369-1374 (1996).
16. HEENAN, M., O'DRISCOLL, L., CLEARY, I., CONNOLLY, L. and CLYNES, M., Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. Int. J. Cancer, 71, 907-915 (1997).
17. L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc. nat. Acad. Sci. (Wash.), 95, 4386-4391 (1998).
18. L as an inhibitor of cytosolic cytochrome c accumulation in DNA damage-induced apoptosis. Proc. nat. Acad. Sci. (Wash.), 94, 6939-6942 (1997).
19. L inhibits Ara-C-induced mitochondrial loss of cytochrome C and other perturbations that activate the molecular cascade of apoptosis. Cancer Res., 57, 3115-3120 (1997).
20. KITADA, S., TAKAYAMA, S., DE RIEL, K., TANAKA, S. and REED, J.C., Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res. Develop., 4, 71-79 (1994).
21. KÜHL, J.S., KRAJEWSKI, S., DURÁN, G.E., REED, J.C. and SIKIC, B.I., Spontaneous overexpression of the long form of the Bcl-x protein in a highly resistant P388 leukaemia. Brit. J. Cancer, 75, 268-274 (1997).
22. MARTIN, A. and CLYNES, M., Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays. Cytotechnology, 11, 49-58 (1993).
23. MASHIMA, T., SEIMIYA, H., CHEN, Z., KATAOKA, S. and TSURUO, T., Apoptosis resistance in tumour cells. Cytotechnology, 27, 293-308 (1998).
24. MCBRIDE, S., MELEADY, P., BAIRD, A., DINSDALE, D. and CLYNES, M., Human lung carcinoma cell line DLKP contains 3 distinct subpopulations with different growth and attachment properties. Tumour Biol., 19, 88-103 (1998).
25. L forms an ion channel in synthetic lipid membranes. Nature (Lond.), 385, 353-357 (1997).
26. O'DRISCOLL, L., DALY, C., SALEH, M. and CLYNES, M., The use of reverse transcriptase polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells. Cytotechnology, 12, 289-314 (1993).
27. L or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Int. J. Cancer, 67, 608-614 (1996).
28. L is heterogenously expressed by acute myeloblastic leukaemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression. Leukemia, 11, 945-949 (1997).
29. PEREGO, P., GIAROLA, M., RIGHETTI, S.C., SUPINO, R., CASERINI, C., DELIA, D., PIEROTTI, M.A., MIYASHITA, T., REED, J.C. and ZUNINO, F., Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res., 56, 556-562 (1996).
30. PISCITELLI, S.C., RODVOLD, K.A., RUSHING, D.A. and TEWKSBURY, D.A., Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer. Clin. Pharmacol. Ther., 53, 555-561 (1993).
31. STROBEL, T., KRAEFT, S.K., CHEN, L.B. and CANNISTRA, S.A., BAX expression is associated with enhanced intracellular accumulation of paclitaxel: a novel role for BAX during chemotherapy-induced cell death. Cancer Res., 58, 4776-4781 (1998).
32. S sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55, 2507-2510 (1995).
33. TEIXEIRA, C., REED, J.C. and PRATT, M.A.C., Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res., 55, 3902-3907 (1995).
34. VOGELBAUM, M.A., TONG, J.X., HIGASHIKUBO, R., GUTMANN, D.H. and RICH, K.M., Transfection of C6 glioma cells with the bax gene and increased sensitivity to treatment with cytosine arabinoside. J. Neurosurg., 88, 99-105 (1998).
35. WAGENER, C., BARGOU, R.C., DANIEL, P.T., BOMMERT, K., MAPARA, M.Y., ROYER, H.D. and DÖRKEN, B., Induction of the death-promoting gene bax-α sensitises cultured breast-cancer cells to drug-induced apoptosis. Int. J. Cancer. 67, 138-141 (1996).
36. YANG, L.Y. and TRUJILLO, J.M., Biological characterization of multidrug-resistant human colon carcinoma sublines induced/selected by two methods. Cancer Res., 50, 3218-3225 (1990).